Global Respiratory Diagnostics Market Analysis By Top Key Players - Philips Healthcare, Abbott Laboratories (ABT), BIOMERIEUX (BIM.PA), Becton, Dickinson and Company (BDX) and more

According to IMARC Group latest published report, titled "Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," that the global respiratory diagnostics market size reached US$ 6.9 Billion in 2021. Looking forward, the market expected to reach US$ 10.9 Billion by 2027, exhibiting a growth rate (CAGR) of 7.73% during 2022-2027.

Year Considered to Estimate the Market Size:
Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027

Respiratory diagnostic, also known as respiratory or lung examination, is the clinical process carried for assessing lung functioning and other related issues. It is generally practiced when the patient experiences chest pain, cough and irritation in the respiratory tract, or irregular breathing patterns, among other medical conditions. Respiratory diagnostic procedures include chest X-ray, oximetry, sniff nasal inspiratory pressure (SNIP), CT scan, and spirometry. Advanced diagnostic methods improve patient management leading to reduced antibiotics dosage, shorter hospital stays, and minimized health risks.

Request for a sample copy of this report: https://www.imarcgroup.com/respiratory-diagnostics-market/requestsample

Respiratory Diagnostics Market Trends

Rapid urbanization, particularly in developing countries, has given rise to sedentary lifestyles, leading to high consumption of tobacco and smoking. Also, the increasing air pollution in countries, like India and China, has accelerated the prevalence of chronic diseases, such as asthma, lung cancer, pulmonary fibrosis, and bronchitis. These factors, coupled with the growing geriatric population, have catalyzed the demand for respiratory diagnostic devices in private hospitals and clinics. Additionally, various technological advancements, such as the introduction of artificial intelligence (AI)-based advanced molecular diagnostic tests, has positively influenced the efficiency of respiratory diagnostics.

Covid-19 Scenario:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/respiratory-diagnostics-market

Competitive Scenario with Key Players:

The competitive landscape of the market has also been analyzed, with some of the key players being: Philips Healthcare, Abbott Laboratories (ABT), BIOMERIEUX (BIM.PA), Becton, Dickinson and Company (BDX), Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, COSMED, etc.

The report cover the below key market segments:

Breakup by Product and Service Type:

Instruments and Services
Assays and Reagents
Services and Software

Breakup by Test Type:

Mechanical Tests
Obstructive Sleep Apnoea (OSA) Diagnostic Tests
Imaging Tests
Traditional Diagnostic Tests
Molecular Diagnostic Tests
Others

Breakup by Disease:

Tuberculosis
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Others

Breakup by End-User:

Hospitals
Clinics
Reference and Clinical Laboratories
Others

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.